CombiMatrix Company

CombiMatrix develops proprietary technologies, products and services for drug development, genetic analysis, molecular diagnostics and more.

Founded Date: 1995
Technology: Cancer
Investor Type: N/A
Funding Status: M&A
Employee Number: 51-100
Headquarters: Irvine, California, United States
Estimated Revenue: $10M to $50M
Investment Stage: N/A
Number Of Exists: N/A
Industry: PharmTech